GAP-Net site Cleveland Clinic is hosting the Cleveland Walk to End Alzheimer’s on October 4, 2020. Guest columnist Caroline James is the Business Development Specialist at Independence Village & StoryPoint Avon Lake and Retention Chair for the Cleveland Walk to End Alzheimer’s. I’ve worked in senior care for seven years, often helping those with dementia or Alzheimer’s […]
GAP President John Dwyer was featured in ACRP about what clinical trials need to be doing to increase awareness and hasten treatments. The clinical trial industry continues to grapple with finding new and more effective ways to expand its efforts to combat Alzheimer’s. The obstacles are real. Alzheimer’s trials cost more per patient than trials […]
Citizen Scientist nominee, Florida State Representative Matt Willhite, from GAP-Net site JEM Research Institute, speaks about his mother’s Alzheimer’s diagnosis and involvement in Biogen’s clinical trial. Surprise and skepticism greeted the Biogen company’s announcement that clinical trials of an antibody called aducanumab were resuming this year. Not only that, Biogen asked the federal Food and […]
GAP President, John Dwyer, was featured in a Wall Street Journal article on the importance of Black, African-American, Hispanic and Latinx communities being aware of and enrolling in Alzheimer’s clinical trials, and what GAP is doing to help. Brian Van Buren applied to five Alzheimer’s disease clinical trials after being diagnosed with mild cognitive impairment […]
GAP’s statement: Study cites limited awareness among patients and physicians, anxiety, and lack of quick diagnostics Washington, DC (August 20, 2020) – The President of the Global Alzheimer’s Platform Foundation (GAP), John Dwyer, issued the following statement regarding a University of Southern California Louis D. Schaeffer Center for Health Policy & Economics white paper, “Key Barriers to […]
GAP-Net site, Syrentis Clinical Research, and GAP President, John Dwyer, were interviewed about the difficulties of recruiting Alzheimer’s clinical trial volunteers in the time of COVID-19, and why their involvement is important. Alzheimer’s disease researchers fear that fewer volunteers and delayed studies due to COVID-19 may hinder the discovery of important treatments for the illness. […]
GAP-Net site, Cleveland Clinic Lou Ruvo Center for Brain Health Las Vegas, was included in the KNPR Top Doctors in Southern Nevada of 2020. How the Top Doctors are selected Castle Connolly Top Doctors is a healthcare research company and the official source for Top Doctors for the past 25 years. Castle Connolly’s established nomination […]
GAP-Net Site Lou Ruvo Center for Brain Health at Cleveland Clinic Las Vegas was quoted about how microbiomes in the gut can affect the brain and lead to Alzheimer’s disease. SHANGHAI, July 29, 2020 /PRNewswire/ — Alzheimer’s disease has been an unsolved puzzle for scientists since the first patient was found over 100 years ago. Different theories […]
Washington D.C. (July 30, 2020) – The President of the Global Alzheimer’s Platform Foundation (GAP), John Dwyer, issued the following statement regarding recent groundbreaking advances in Alzheimer’s blood test research: “I want to congratulate and thank Dr. Barthélemy, Dr. Horie, Dr. Sato, Dr. Bateman, Dr. Palmqvist, Dr. Janelidze, and Dr. Quiroz on their published research on two […]
GAP-Net site Washington University in St. Louis helped develop one of the tests that has diagnosed the disease as accurately as methods that are far more expensive or invasive. Banner Alzheimer’s Institute was also mentioned as a senior author. A newly developed blood test for Alzheimer’s has diagnosed the disease as accurately as methods that […]
GAP-Net site Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas was featured on FOX5 about Alzheimer’s clinical trial setbacks due to COVID-19, and how important minority communities are to research. Click here to watch the full interview. LAS VEGAS (FOX5) — Dr. Aaron Ritter with the Cleveland Clinic Lou Ruvo Center for […]
Dr. Jeffrey Cummings from GAP-Net site, Lou Ruovo Center for Brain Health at Cleveland Clinic in Las Vegas was interviewed by NeurologyLive about developments in Alzheimer’s disease research that are worth holding out hope for. A systematic review of Alzheimer disease (AD) treatments currently in development demonstrate the progressive emphasis on nonamyloid targets, including candidate […]
Below is a press release from GAP-Net site, Okanagan Clinical Trials, regarding a high profile member of the community completeing a memory assessment. Kelowna (July 21, 2020) – Maxine Dehart, local city councillor, hotelier and journalist, decided to book a memory assessment for herself after featuring Okanagan Clinical Trials as part of her Straight from DeHart column in May. […]
GAP-Net sites Butler Hospitals Memory and Aging Program and Rhode Island Hospitals Alzheimer’s Disease and Memory Disorders Center were featured on 10WJAR in Providence, RI about an Alzheimer’s clinical trial that looks to prevent the disease before symptoms occur. A new clinical trial is aimed at preventing Alzheimer’s years before symptoms arise. There will be […]
GAP-Net site Brigham and Women’s Center for Alzheimers Research and Treatment received a $25 million donation. Brigham and Women’s Hospital has received a $25 million gift to establish and support a new Alzheimer’s prevention program, the Boston-based organization said July 13. The gift, from Andrew and Kate Davis and the Shelby Cullom Davis Charitable Fund, will […]
GAP-Net site Brigham and Women’s CART was featured with two of their Citizen Scientists in the Boston Business Journal about COVID-related delays and the dedication of AD volunteers. Joining a clinical trial may not be the first idea that pops into your head when wondering how to make new friends after moving to a new […]
GAP-Net site, UCI Mind at the University of California Irvine, was awarded an Alzheimer’s research grant by the National Institute of Health The National Institutes of Health has awarded $14.4 million to the UCI MIND institute at UC Irvine to continue its crucial work in the study of Alzheimer’s disease, for which there remains no […]
GAP President John Dwyer wrote a piece in The Hill urging Congress to ensure research centers involved in Alzheimer’s clinical trials will have access to COVID-19 relief funds. COVID-19 has had a devastating impact on clinical trials and the medical research infrastructure that scientists depend upon to develop new drugs for Alzheimer’s and all the diseases we fear most. Without action, […]
Washington D.C. (July 9, 2020) – The President of the Global Alzheimer’s Platform Foundation (GAP), John Dwyer, issued the following statement regarding Biogen’s submission of its BLA application for Aducanumab with the FDA: “The Alzheimer’s research community is looking forward to a thoughtful review of Aducanumab and ideally, approval by the FDA. This application represents a singular […]
GAP President, John Dwyer, and GAP-Net site Great Lakes Clinical Trial spoke on the hit Alzheimer’s clinical trials have taken since COVID-19, and the losses that will come of it. After a frustrating 2019, Alzheimer’s researchers had reason to look forward to 2020 as a year of promise. Then the pandemic struck. “Last year, seven […]
Alice Bailey, a GAP Citizen Scientist Award nominee, wrote an Op-Ed piece in the Cambridge Chronicle about her experience as an Alzheimer’s patient and clinical trial volunteer. For many seniors, Alzheimer’s disease is surrounded by fear. Fear of the diagnosis can be so strong that some don’t want to learn about or talk about the […]
GAP President John Dwyer and GAP-Net Site Roper St. Francis Healthcare Research and Innovation Center in Charleston, South Carolina were featured on LIVE 5 WCSC News about the need for Alzheimer’s clinical trials to begin again. CHARLESTON, S.C. (WCSC) – Medical experts are worried that the COVID-19 pandemic has put delays on the search for […]
GAP President John Dwyer was quoted in AlzForum about the challenges and changes in Alzheimer’s clinical trials due to COVID-19. As Alzheimer’s research comes to, scientists are taking stock of the damage. In the academic world, the main cost was time (see Part 1 of this story). For most clinical studies, the damage was more tangible, with […]
GAP-Net Site, Brigham and Women’s Center for Alzheimer’s Research and Treatment, and GAP President, John Dwyer, were featured on Boston 25 News talking about how Alzheimer’s Clinical Trial volunteers and researchers are getting back on track after COVID-19 setbacks. The pandemic has put a pause on critical medical research. At Brigham and Women’s Hospital, some […]